Stryker击败了Q1的预期收入, 宣布股息, 保留了“Moderate Buy”分析师评分。 Stryker beats Q1 earnings expectations, announces dividend, retains "Moderate Buy" analyst rating.

Stryker Corporation(一家医疗技术公司)在Q1 2020年的股份略有下降,但比预期的收益低,每股2.84美元,收入58.7亿美元。 Stryker Corporation, a medical technology firm, saw its shares drop slightly in Q1 2020, but it beat earnings expectations with $2.84 per share and $5.87 billion in revenue. 该公司宣布季度股息为每股0.84美元,7月31日支付。 The company announced a quarterly dividend of $0.84 per share, payable on July 31. Stryker虽然被机构投资者出售, 却得到分析家一致认同的“机动购买”评级, 目标价为427. 30美元。 Despite some selling by institutional investors, Stryker has received a consensus "Moderate Buy" rating from analysts, with a target price of $427.30.